Activity value 90south korea Buyer&Supplier,Last transaction date:
2025-12-16Address: 263, yeonji-dong, jongno-gu, seoul (seoul 110-470 korea) rep of korea
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for samyang biopharmaceuticals corp. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 2 transactions, with a transaction quantity of 20.05 and a transaction weight of 0.
5biocon ltd.
indiabuyer,they trade on 2018-06-19
42.33%
>
+View All
Products
Total 4
ProductsTransactionsPerDetail
azacitidine 1270.59%>
ruxolitinib 423.53%>
phosphate 211.76%>
decitabine 15.88%>
Hscode rank
Total 39
HSCode NameTransactionsPerDetail
HS 29349990847.06%>
HS 29419019529.41%>
HS 29337990423.53%>
Trading Area
Total 1
AreaTransactionsPerDetail
india7443.02%>
Port statistics
Total 5
Port NameTransactionsPerDetail
seoul incheon int2816.28%>
seoul84.65%>
incheon intl apt seoul21.16%>
incheon intl apt/seoul21.16%>
seoul kimpo apt21.16%>
samyang biopharmaceuticals corp. is south korea Buyer&Supplier,
and primarily engages in the import and export business of products such as azacitidine,ruxolitinib,phosphate.
According to the 52wmb.com global trade database, as of 2025-12-16, the company has completed 2193 international trades,
with its main trading regions covering india etc.
The core products include HS29349990,HS29419019,HS29337990 etc,
often transported via seoul incheon int,port seoul, port incheon intl apt seoul etc,
and its main trading partners are shilpa medicare ltd.,shodhana laboratories ltd.,mco hospital aidspvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on samyang biopharmaceuticals corp. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.